FDA CDRH To Host Virtual Workshop to Enhance Clinical Study Diversity
The FDA, in collaboration with the Clinical Trials Transformation Initiative (CTTI), is soliciting input on how to enhance clinical study diversity. They will be hosting a two-day virtual public workshop on increasing the enrollment of historically underrepresented populations in clinical studies and encouraging clinical study participation that reflects the prevalence of the disease or condition among demographic subgroups. The workshop is scheduled for Wednesday, November 29, and Thursday, November 30, 2023, from 10:00am-2:00pm ET.
During the event, drug sponsors, medical device sponsors, clinical research organizations, academia, patients and other stakeholders will share their experiences and approaches for increasing enrollment and encouraging participation of historically underrepresented populations in clinical studies.
Registration will be opening soon. If you have questions about this workshop, email cdrhhealthequity@fda.hhs.gov.
Related Articles
-
The agency has released a draft guidance outlining its policy for accepting data from foreign clinical studies.
-
The agency is seeking more participation among different genders, ages, races and ethnic groups.
-
“Approaches to Increasing Diversity in Clinical Research and Addressing Health Inequities” offers key recommendations for device manufacturers and developers on steps they can take to increase diversity in clinical research and address health equity.
-
The agency will bring together major stakeholders to discuss challenges in medical device cybersecurity.
Original post: https://medtechintelligence.com/news_article/fda-cdrh-to-host-virtual-workshop-to-enhance-clinical-study-diversity/
Post publish date:
